
|Articles|May 21, 2009
Predicting diabetic retinopathy progression
A diabetic retinopathy (DR) progression biomarker software has been developed with the research institute AIBILI (Association for Biomedical Research and Innovation in Light and Image) and Critical Health. The RetmarkerDR is able to calculate and provide important ratios regarding Microaneurysm Turnover (formation and disappearance rates) which are key indicators of progression of retinal diseases like Diabetic Retinopathy.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma
2
Broadening horizons: Expanding your surgical portfolio with SMILE pro for Hyperopia
3
IGS 2026: Current clinical perspectives on optic disc drusen
4
IGS 2026: The expanding role of artificial intelligence in ophthalmology
5




























